Nomura Holdings
NGNE icon

Nomura Holdings’s Neurogene NGNE Stock Holding History

Nomura Holdings’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,724
Closed -$257K – 1970
2026
Q1 		$257K Buy
+12,724
New +$246K ﹤0.01% 1520
2023
Q1 		– Sell
-812
Closed -$8K – 1647
2022
Q4 		$8K Hold
812
– – ﹤0.01% 1383
2022
Q3 		$11K Hold
812
– – ﹤0.01% 1525
2022
Q2 		$16K Buy
812
+37
+5% +$903 ﹤0.01% 1626
2022
Q1 		$29K Buy
775
+13
+2% +$758 ﹤0.01% 1805
2021
Q4 		$74K Sell
762
-13
-2% -$1.58K ﹤0.01% 2027
2021
Q3 		$114K Hold
775
– – ﹤0.01% 1763
2021
Q2 		$145K Hold
775
– – ﹤0.01% 1790
2021
Q1 		$190K Hold
775
– – ﹤0.01% 1650
2020
Q4 		$221K Buy
+775
New +$189K ﹤0.01% 1377

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Nomura Holdings's NGNE Position: Q2 2026 in Review

Nomura Holdings sold out of Neurogene (NGNE) in Q2 2026, closing a stake of 12,724 shares — an estimated $257K sold.

Nomura Holdings first reported a position in NGNE in Q4 2020 and held it in 10 quarters. The position peaked at $257K in Q1 2026. 112 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Nomura Holdings reported no remaining Neurogene position as of Q2 2026 after selling out during the quarter.
  • Nomura Holdings sold 12,724 Neurogene shares in Q2 2026, an estimated $257K.
  • Nomura Holdings first reported a position in Neurogene in Q4 2020 and held it in 10 quarters.
  • Nomura Holdings's Neurogene position peaked at $257K in Q1 2026.
  • 112 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.